意達利控股(00720.HK)前10個月收入減少及税前虧損擴大
格隆匯11月18日丨意達利控股(00720.HK)公佈,與2018年同期相比,公司截至2019年10月31日止10個月的收入減少及除所得税前虧損擴大。該集團於截至2019年10月31日止10個月的未經審核收入約為20,600萬港元,而2018年同期則約為28,900萬港元;期間未經審核除所得税前虧損約為800萬港元,而2018年同期則約為100萬港元。
有關虧損乃主要歸因於汽車分部的收入因香港社會持續動盪導致經濟環境不明朗及市場氣氛疲弱而有所下降。預期本年餘下時間的經營環境仍充滿挑戰。儘管上文所述,董事會相信,該集團的整體財務狀況依然穩健,故董事會對該集團的長遠發展仍保持正面態度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.